Cargando…

An interpretable ML model to characterize patient-specific HLA-I antigen presentation

Personalized immunotherapy holds the promise of revolutionizing cancer prevention and treatment. However, selecting HLA-bound peptide targets that are specific to patient tumors has been challenging due to a lack of patient-specific antigen presentation models. Here, we present epiNB, a white-box, p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Shaoheng, Jiang, Xianli, Chiu, Yulun, Xu, Haodong, Kim, Kun Hee, Lizee, Gregory, Chen, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054957/ https://www.ncbi.nlm.nih.gov/pubmed/36993682 http://dx.doi.org/10.1101/2023.03.12.532264

Ejemplares similares

Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I molecules
por: Jackson, Kyle R, et al.
Publicado: (2022)

Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity
por: Bassani-Sternberg, Michal, et al.
Publicado: (2017)

Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation
por: Huang, Man, et al.
Publicado: (2016)

Determining if T cell antigens are naturally processed and presented on HLA class I molecules
por: Friedman, Jay, et al.
Publicado: (2022)

Theory perspective on ML jet analyses and the interpretability of their results
por: Thaler, Jesse
Publicado: (2021)

No silver bullet: interpretable ML models must be explained
por: Marques-Silva, Joao, et al.
Publicado: (2023)

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
por: van den Ingh, H. F., et al.
Publicado: (1987)

RBM-MHC: A Semi-Supervised Machine-Learning Method for Sample-Specific Prediction of Antigen Presentation by HLA-I Alleles
por: Bravi, Barbara, et al.
Publicado: (2021)

HLA-Arena: A Customizable Environment for the Structural Modeling and Analysis of Peptide-HLA Complexes for Cancer Immunotherapy
por: Antunes, Dinler A., et al.
Publicado: (2020)

Natural HLA Class I Polymorphism Controls the Pathway of Antigen Presentation and Susceptibility to Viral Evasion
por: Zernich, Danielle, et al.
Publicado: (2004)

MHC Class I Endosomal and Lysosomal Trafficking Coincides with Exogenous Antigen Loading in Dendritic Cells
por: Basha, Genc, et al.
Publicado: (2008)

ROLE OF HLA CLASS-I ANTIGENS IN DELUSIONAL DISORDER
por: Debnath, Monojit, et al.
Publicado: (2000)

Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms
por: Saulle, Irma, et al.
Publicado: (2021)

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
por: Chiu, Yen-Ling, et al.
Publicado: (2011)

Interpretability of Machine Learning Solutions in Public Healthcare: The CRISP-ML Approach
por: Kolyshkina, Inna, et al.
Publicado: (2021)

Genetic modulation of antigen presentation by HLA-B27 molecules
Publicado: (1992)

The role of antigen expression in shaping the repertoire of HLA presented ligands
por: Garcia Alvarez, Heli M., et al.
Publicado: (2022)

Melanoma and Human Leukocyte Antigen (HLA): Immunogenicity of 69 HLA Class I Alleles With 11 Antigens Expressed in Melanoma Tumors
por: Georgopoulos, Apostolos P, et al.
Publicado: (2023)

Proteome Sampling by the HLA Class I Antigen Processing Pathway
por: Hoof, Ilka, et al.
Publicado: (2012)

HLA-DP(84Gly) constitutively presents endogenous peptides generated by the class I antigen processing pathway
por: Yamashita, Yuki, et al.
Publicado: (2017)

Expression of classical human leukocyte antigen class I antigens, HLA‐E and HLA‐G, is adversely prognostic in pancreatic cancer patients
por: Hiraoka, Nobuyoshi, et al.
Publicado: (2020)

HLA-DO and Its Role in MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

MR1- and HLA-E-Dependent Antigen Presentation of Mycobacterium tuberculosis
por: Kim, Se-Jin, et al.
Publicado: (2022)

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
por: Chiu, Peter Ka-Fung, et al.
Publicado: (2016)

PepSim: T-cell cross-reactivity prediction via comparison of peptide sequence and peptide-HLA structure
por: Hall-Swan, Sarah, et al.
Publicado: (2023)

Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis
por: Kan, Hung-Cheng, et al.
Publicado: (2017)

Tumour‐associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles
por: Kumar, Pankaj, et al.
Publicado: (2022)

Direct evidence for binding of CD8 to HLA class I antigens
Publicado: (1989)

Human Leukocyte Antigen (HLA) class I and II datasets for sudanese
por: Dafalla, Ameer Mohamed, et al.
Publicado: (2019)

2014: Identification of novel shared tumor antigens for the development of T-cell-based immunotherapies
por: Bradley, Sherille, et al.
Publicado: (2018)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml
por: Umezawa, Rei, et al.
Publicado: (2011)

Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
Publicado: (1996)

Insights into the Role of GILT in HLA Class II Antigen Processing and Presentation by Melanoma
por: Norton, Duncan L., et al.
Publicado: (2009)

Association of Polymorphisms in HLA Antigen Presentation-Related Genes with the Outcomes of HCV Infection
por: Huang, Peng, et al.
Publicado: (2015)

HLA-DO as the Optimizer of Epitope Selection for MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

HLA-B and cysteinylated ligands distinguish the antigen presentation landscape of extracellular vesicles
por: Bauzá-Martinez, Julia, et al.
Publicado: (2021)

Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera
Publicado: (1988)

c-Myc and EBV–LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells
por: Tudor, C S, et al.
Publicado: (2012)

Diversity of Natural Self-Derived Ligands Presented by Different HLA Class I Molecules in Transporter Antigen Processing-Deficient Cells
por: Lorente, Elena, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_eh5ihmvec221cvejgkk8k6de10